These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16218917)

  • 21. Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transfer.
    Enomaa N; Danos O; Peltonen L; Jalanko A
    Hum Gene Ther; 1995 Jun; 6(6):723-31. PubMed ID: 7548272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A family with two children diagnosed with aspartylglucosaminuria-case report and literature review].
    Liu Y; Zou L; Meng Y; Zhang Y; Shi X; Ju J; Yang G; Hu L; Chen X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):455-9. PubMed ID: 25190167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal diagnosis and fetal pathology of aspartylglucosaminuria.
    Aula P; Rapola J; von Koskull H; Ammälä P
    Am J Med Genet; 1984 Oct; 19(2):359-67. PubMed ID: 6507482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel aspartylglucosaminuria mutation affects translocation of aspartylglucosaminidase.
    Saarela J; von Schantz C; Peltonen L; Jalanko A
    Hum Mutat; 2004 Oct; 24(4):350-1. PubMed ID: 15365992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follow-up in patients with aspartylglucosaminuria. Part I. The course of intellectual functions.
    Arvio M
    Acta Paediatr; 1993 May; 82(5):469-71. PubMed ID: 8518524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland.
    Syvänen AC; Ikonen E; Manninen T; Bengtström M; Söderlund H; Aula P; Peltonen L
    Genomics; 1992 Mar; 12(3):590-5. PubMed ID: 1559710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular genetics of aspartylglucosaminuria].
    Palotie L; Ikonen E; Syvänen AC; Halila R; Enomaa N; Heiskanen T; Grön K; Aula P
    Duodecim; 1991; 107(23-24):1916-25. PubMed ID: 1366100
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship between head circumference and brain volume in healthy normal toddlers, children, and adults.
    Bartholomeusz HH; Courchesne E; Karns CM
    Neuropediatrics; 2002 Oct; 33(5):239-41. PubMed ID: 12536365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse.
    Virta S; Rapola J; Jalanko A; Laine M
    J Gene Med; 2006 Jun; 8(6):699-706. PubMed ID: 16518877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone-marrow transplantation in aspartylglucosaminuria.
    Autti T; Santavuori P; Raininko R; Renlund M; Rapola J; Saarinen-Pihkala U
    Lancet; 1997 May; 349(9062):1366-7. PubMed ID: 9149703
    [No Abstract]   [Full Text] [Related]  

  • 31. Aspartylglucosaminuria in a Puerto Rican family: additional features of a panethnic disorder.
    Chitayat D; Nakagawa S; Marion RW; Sachs GS; Hahm SY; Goldman HS
    Am J Med Genet; 1988 Nov; 31(3):527-32. PubMed ID: 3228136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head growth in preterm infants: correlation with magnetic resonance imaging and neurodevelopmental outcome.
    Cheong JL; Hunt RW; Anderson PJ; Howard K; Thompson DK; Wang HX; Bear MJ; Inder TE; Doyle LW
    Pediatrics; 2008 Jun; 121(6):e1534-40. PubMed ID: 18519457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epileptic seizures in aspartylglucosaminuria: a common disorder.
    Arvio M; Oksanen V; Autio S; Gaily E; Sainio K
    Acta Neurol Scand; 1993 May; 87(5):342-4. PubMed ID: 8333236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep disturbances in aspartylglucosaminuria (AGU): a questionnaire study.
    Lindblom N; Kivinen S; Heiskala H; Laakso ML; Kaski M
    J Inherit Metab Dis; 2006 Oct; 29(5):637-46. PubMed ID: 16944277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular analysis of the aspartylglucosaminidase gene in Japanese patients with aspartylglucosaminuria].
    Yoshida K
    Nihon Rinsho; 1993 Sep; 51(9):2308-13. PubMed ID: 8411707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amlexanox provides a potential therapy for nonsense mutations in the lysosomal storage disorder Aspartylglucosaminuria.
    Banning A; Schiff M; Tikkanen R
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):668-675. PubMed ID: 29247835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of exon 8 causes glycosylasparaginase deficiency in an African American aspartylglucosaminuria (AGU) patient.
    Fisher KJ; Aronson NN
    FEBS Lett; 1991 Aug; 288(1-2):173-8. PubMed ID: 1879549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzymatic diagnosis of aspartylglycosaminuria by fluorometric assay of glycosylasparaginase in serum, plasma, or lymphocytes.
    Mononen I; Mononen T; Ylikangas P; Kaartinen V; Savolainen K
    Clin Chem; 1994 Mar; 40(3):385-8. PubMed ID: 8131272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspartylglucosaminuria: radiologic course of the disease with histopathologic correlation.
    Autti T; Raininko R; Haltia M; Lauronen L; Vanhanen SL; Salonen O; Aronen HJ; Wirtavuori K; Santavuori P
    J Child Neurol; 1997 Sep; 12(6):369-75. PubMed ID: 9309520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow transplantation for aspartylglucosaminuria: follow-up study of transplanted and non-transplanted patients.
    Arvio M; Sauna-Aho O; Peippo M
    J Pediatr; 2001 Feb; 138(2):288-90. PubMed ID: 11174635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.